By Ramsey Baghdadi
Is FDA using a comparative effectiveness standard for making approval decisions in certain drug classes? What role does drug safety...
The FDA Roundtable Part I: The Regulators' View of Drug Development
Three top FDA officials sat down with The RPM Report at their White Oak campus to discuss the top drug regulatory issues. On the table for discussion: drug safety, comparative effectiveness and the future of drug development.